Diazepam-mediated inhibition of human immunodeficiency virus type 1 expression in human brain cells

Area of Science:

• Neuroscience
• Immunology
• Virology

Background:

• Human immunodeficiency virus type 1 (HIV-1) can infect various cell types, including brain cells and immune cells like macrophages and microglial cells.
• Understanding cellular mechanisms that regulate HIV-1 replication is crucial for developing effective therapeutic strategies.
• Nuclear factor kappa B (NF-κB) is a key transcription factor involved in immune responses and viral replication.

Purpose of the Study:

• To investigate the effect of diazepam on HIV-1 replication in different human cell types.
• To explore the underlying molecular mechanisms, specifically the role of NF-κB activation, in diazepam's antiviral activity.

Main Methods:

• Treatment of acutely infected human brain and microglial cell cultures with diazepam.
• Treatment of chronically infected promonocytic (U1) cells and acutely infected monocyte-derived macrophages with diazepam.
• Measurement of HIV-1 p24 antigen expression as an indicator of viral replication.
• Assessment of nuclear factor kappa B (NF-κB) activation.

Main Results:

• Diazepam significantly inhibited HIV-1 p24 antigen expression in acutely infected human brain and microglial cells.
• Diazepam suppressed HIV-1 expression in chronically infected U1 cells and acutely infected monocyte-derived macrophages.
• The observed antiviral activity of diazepam was associated with decreased activation of NF-κB.

Conclusions:

• Diazepam exhibits antiviral properties against HIV-1 in various human cell types, including neural and immune cells.
• The inhibitory effect of diazepam on HIV-1 replication may be mediated through the suppression of NF-κB activation.
• These findings suggest a potential role for diazepam or related compounds in managing HIV-1 infection, particularly in the central nervous system.